Related Experiment Video
Updated: Jun 1, 2026

Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates
Published on: February 17, 2023
Enterococcus avium bacteremia: a 12-year clinical experience with 53 patients
1Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, 86, Asanbyeongwon-gil, Songpa-gu, Seoul, 138-736, Republic of Korea.
Enterococcus avium bacteremia, often originating from biliary or abdominal infections, presents a significant mortality risk. Inadequate antimicrobial therapy and severe underlying conditions independently increase patient mortality.
Area of Science:
- Infectious Diseases
- Clinical Microbiology
- Epidemiology
Background:
- Enterococcus avium bacteremia is infrequently reported, with limited understanding of its clinical manifestations and patient outcomes.
- Formerly known as "group Q streptococcus," E. avium's role in bloodstream infections requires further investigation.
Purpose of the Study:
- To retrospectively analyze the clinical features and outcomes of patients experiencing Enterococcus avium bacteremia.
- To identify risk factors associated with mortality in E. avium bacteremia.
Main Methods:
- Retrospective evaluation of 53 patients with E. avium bacteremia at a tertiary-care hospital in Korea (1997-2009).
- Data collected included infection source, polymicrobial status, nosocomial acquisition, vancomycin resistance, and mortality rates.
- Multivariate analysis was employed to determine independent risk factors for mortality.
Main Results:
- E. avium bacteremia commonly arose from biliary (50.9%) or intra-abdominal (24.5%) sources, frequently in polymicrobial settings (67.9%).
- Nosocomial bloodstream infections accounted for 62.3% of cases; no vancomycin resistance was observed.
- Crude mortality was 24.5%, with an E. avium bacteremia-related mortality of 11.3%.
Conclusions:
- Enterococcus avium bacteremia is often linked to biliary/intra-abdominal infections and polymicrobial bacteremia, carrying a considerable crude mortality rate.
- Severe underlying disease and inadequate antimicrobial therapy were identified as significant independent risk factors for mortality in E. avium bacteremia patients.
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Acute Pyelonephritis II: Diagnostic Studies and Management
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Clinical Significance of Antibiotic Resistance
Acute Pyelonephritis I: Introduction

